Kenneth Stillwell sold $834k of PEGA
COO, CFO at PEGASYSTEMS INC. 14,405 shares at an average of $57.87, traded Dec 5, 2025, filed Dec 9, 2025.
Score components
- +22RoleCFO
- +23Trade size$834k at market
- 0Share of holdings soldSold 9.9% of holdings
- +15Cluster3 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -3.0%, 3m -27.1%, 6m -44.2%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001680115-25-000018, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Dec 5, 2025 | MOption exercise Common stock | +4,402 | $0.00 | $0 | 134,352 | Dec 9, 2025 |
| Dec 5, 2025 | FTax withholding Common stock | -1,733 | $57.00 | $99k | 132,619 | Dec 9, 2025 |
| Dec 5, 2025 | MOption exercise Common stock | +29,240 | $32.18 | $941k | 161,859 | Dec 9, 2025 |
| Dec 5, 2025 | MOption exercise Common stock | +20,000 | $31.05 | $621k | 181,859 | Dec 9, 2025 |
| Dec 5, 2025 | FTax withholding Common stock | -35,833 | $57.56 | $2.1M | 146,026 | Dec 9, 2025 |
| Dec 5, 2025 | SOpen-market sale Common stock | -7,821 | $57.89 | $453k | 138,205 | Dec 9, 2025 |
| Dec 5, 2025 | SOpen-market sale Common stock | -5,586 | $57.86 | $323k | 132,619 | Dec 9, 2025 |
| Dec 5, 2025 | SOpen-market sale Common stock | -998 | $57.75 | $58k | 131,621 | Dec 9, 2025 |
| Dec 7, 2025 | MOption exercise Common stock | +5,222 | $0.00 | $0 | 136,843 | Dec 9, 2025 |
| Dec 7, 2025 | FTax withholding Common stock | -2,055 | $60.11 | $124k | 134,788 | Dec 9, 2025 |
| Dec 5, 2025 | MOption exercise Restricted Stock Unitsderivative | -4,402 | $0.00 | $0 | 39,620 | Dec 9, 2025 |
| Dec 5, 2025 | MOption exercise Stock Optionsderivative | -29,240 | $0.00 | $0 | 0 | Dec 9, 2025 |
| Dec 5, 2025 | MOption exercise Stock Optionsderivative | -20,000 | $0.00 | $0 | 0 | Dec 9, 2025 |
| Dec 7, 2025 | MOption exercise Restricted Stock Unitsderivative | -5,222 | $0.00 | $0 | 26,104 | Dec 9, 2025 |
Related signals
Other insiders at PEGASYSTEMS INC and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 1Weak | PEGASYSTEMS INC | Dianne Ledingham director | $34k 1,000 shares | -3% | |
| 46Moderate | PEGASYSTEMS INC | Efstathios A Kouninis SVP, Chief Accounting Officer | $37k 982 shares | -49% | |
| 16Weak | PEGASYSTEMS INC | Dianne Ledingham director | $38k 1,000 shares | -2% | |
| 43Moderate | PEGASYSTEMS INC | Rifat Kerim Akgonul Chief Product Officer | $252k 7,000 shares | -6% | |
| 72Notable | PEGASYSTEMS INC | Kenneth Stillwell COO, CFO | $1.4M 39,627 shares | -29% | |
| 31Weak | PEGASYSTEMS INC | Efstathios A Kouninis SVP, Chief Accounting Officer | $41k 1,063 shares | -48% | |
| 41Moderate | PEGASYSTEMS INC | Efstathios A Kouninis SVP, Chief Accounting Officer | $37k 1,012 shares | -50% | |
| 33Weak | PEGASYSTEMS INC | Rifat Kerim Akgonul Chief Product Officer | $102k 3,000 shares | -3% | |
| 42Moderate | PEGAsell PEGASYSTEMS INC | Efstathios A Kouninis SVP, Chief Accounting Officer | $56k 1,720 shares | -63% | |
| 20Weak | PEGAsell PEGASYSTEMS INC | Efstathios A Kouninis SVP, Chief Accounting Officer | $24k 750 shares | -24% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.